Search

Search Constraints

You searched for: Author/Creator Molenaar, Jan J.

Search Results

1. Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses. (January 2021)

2. Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer. Issue 2 (24th August 2020)

4. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'. (November 2022)

5. MiR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Issue 6 (5th August 2014)

6. Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics. Issue 6 (26th April 2022)

7. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Issue 1 (28th September 2015)

8. MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma. Issue 1 (28th September 2015)

9. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease. Issue 4 (17th November 2019)

10. Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of a Patient Cohort. Issue 1 (21st April 2021)